Gelmek Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 20-06-2024
- Paid Up Capital ₹ 0.10 M
as on 20-06-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 20-06-2024
- Revenue %
(FY 2020)
- Profit -739.23%
(FY 2020)
- Ebitda -973.64%
(FY 2020)
- Net Worth -545.48%
(FY 2020)
- Total Assets 1093.62%
(FY 2020)
About Gelmek Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Harish Rijhwani, Bhavik Jain, Karan Rijhwani, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24304GJ2018PTC104041
- Company No.
104041
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Sep 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Gelmek Healthcare Private Limited offer?
Gelmek Healthcare Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Nutraceuticals & Dietary Supplements, Mineral Supplement, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Muscle Relaxant, Aceclofenac, Cardiovascular Drugs & Medication, Cholesterol Medicine.
Who are the key members and board of directors at Gelmek Healthcare?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Purushottam Gupta  | Director | 11-Sep-2018 | Current |
| Karan Rijhwani | Director | 11-Sep-2018 | Current |
| Harish Rijhwani | Director | 11-Sep-2018 | Current |
| Bhavik Jain | Director | 11-Sep-2018 | Current |
| Kshitij Jain | Director | 27-Jul-2022 | Current |
| Arupee Gupta | Director | 27-Jul-2022 | Current |
Financial Performance of Gelmek Healthcare.
Gelmek Healthcare Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 739.23% decrease in profit. The company's net worth observed a substantial decline by a decrease of 545.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gelmek Healthcare?
Unlock access to Gelmek Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Fitwel Pharmaceuticals Private LimitedActive 10 years 5 monthsBhavik Jain and Kshitij Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 05 Jul 2022 | ₹1.00 Cr | Open |
How Many Employees Work at Gelmek Healthcare?
Unlock and access historical data on people associated with Gelmek Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gelmek Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gelmek Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
